Elanco Animal Health has partnered with Medgene to launch the first highly pathogenic avian influenza vaccine for dairy ...

President Donald Trump’s nominee to lead the Food and Drug Administration was grilled Thursday over whether he would reverse ...

Cornell researchers have developed a stable, multi-target vaccine offering long-lasting protection against COVID-19 and ...

Questioned by senators at a Thursday hearing, President Trump's FDA nominee said he would reevaluate which scientific topics ...

Cornell researchers have developed a new vaccine platform that could provide more robust, longer-lasting protection from both ...

“Findings in this report show that vaccination with the 2024–2025 influenza vaccine reduced the likelihood of medically attended influenza and support CDC’s recommendation that all persons aged ≥6 ...

The new vaccine addresses significant limitations of existing COVID-19 and flu vaccines. While mRNA COVID-19 vaccines require ...

The meeting is the second federal vaccine panel meeting Trump administration officials have canceled or postponed since RFK ...

An FDA vaccine advisory committee meeting to discuss next season’s flu vaccine has been canceled, potentially delaying the ...

U.S. Secretary of Agriculture Brooke Rollins announced a $1 billion-dollar comprehensive strategy to curb highly pathogenic ...

The influenza vaccine for the 2024/2025 season provided moderate protection against influenza A and strong protection against ...

After speculation as to whether this year’s flu vaccine could be poorly matched to the current strain of flu, new Centers for ...